Aortic endovascular repair
The proof is in the results.
You’re invested in durable outcomes for your patients. So are we. Medtronic maintains the longest-term aortic clinical evidence in the industry. We are invested in building the strength of aortic evidence that answers key clinical questions and elevates the standard of care.
Medtronic maintains the longest-term clinical evidence in the industry, consistently showing successful clinical outcomes across different patient anatomies and the entire aortic portfolio.
We are continuing to build our body of evidence by investing in randomized controlled trials (RCTs).
As the first and only EVAR (endovascular aortic repair) system with a decade of global registry outcomes, Endurant systems continue to prove durability and strength in evidence with consistently high sac regression and low aneurysm-related mortality (ARM).1
Choose the standard of EVAR durability.
Risks associated with EVAR procedures may include rupture, conversion to open repair, or secondary procedures.
Valiant Captivia system provides consistent clinical performance across a variety of pathologies and five-year outcomes in all descending thoracic aortic (DTA) pathologies.
Risks associated with TEVAR procedures may include rupture, conversion to open repair, or secondary procedures.
EndoSuture aneurysm repair (ESAR) with the Heli-FX EndoAnchor system continues to demonstrate durable results in challenging patient with low type Ia endoleaks, low reinterventions, and positive sac regression rates.2
Risks may include failure to prevent/correct type I endoleaks, migration, or sac enlargement.
Access interactive courses, case studies, presentations, and videos from your phone, tablet, or desktop.
Sign up for upcoming aortic events, training opportunities, and updates.
Verhagen H, et al. The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.
Jordan WD, Jr. New Developments from the ANCHOR Registry: Early 5 Year Prophylactic Results. Presented at VEITH Symposium 2021; Orlando, Florida.